Literature DB >> 11083774

Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine.

K R Turbyfill1, A B Hartman, E V Oaks.   

Abstract

The invasiveness and virulence of Shigella spp. are largely due to the expression of plasmid-encoded virulence factors, among which are the invasion plasmid antigens (Ipa proteins). After infection, the host immune response is directed primarily against lipopolysaccharide (LPS) and the virulence proteins (IpaB, IpaC, and IpaD). Recent observations have indicated that the Ipa proteins (IpaB, IpaC, and possibly IpaD) form a multiprotein complex capable of inducing the phagocytic event which internalizes the bacterium. We have isolated a complex of invasins and LPS from water-extractable antigens of virulent shigellae by ion-exchange chromatography. Western blot analysis of the complex indicates that all of the major virulence antigens of Shigella, including IpaB, IpaC, and IpaD, and LPS are components of this macromolecular complex. Mice or guinea pigs immunized intranasally with purified invasin complex (invaplex), without any additional adjuvant, mounted a significant immunoglobulin G (IgG) and IgA antibody response against the Shigella virulence antigens and LPS. The virulence-specific response was very similar to that previously noted in primates infected with shigellae. Guinea pigs (keratoconjunctivitis model) or mice (lethal lung model) immunized intranasally on days 0, 14, and 28 and challenged 3 weeks later with virulent shigellae were protected from disease (P<0.01 for both animal models).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083774      PMCID: PMC97759          DOI: 10.1128/IAI.68.12.6624-6632.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain.

Authors:  T Samandari; K L Kotloff; G A Losonsky; W D Picking; P J Sansonetti; M M Levine; M B Sztein
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

2.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

3.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

4.  Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp.

Authors:  G Adamus; M Mulczyk; D Witkowska; E Romanowska
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

5.  Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.

Authors:  S B Formal; E V Oaks; R E Olsen; M Wingfield-Eggleston; P J Snoy; J P Cogan
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

6.  Molecular cloning of invasion plasmid antigen (ipa) genes from Shigella flexneri: analysis of ipa gene products and genetic mapping.

Authors:  J M Buysse; C K Stover; E V Oaks; M Venkatesan; D J Kopecko
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

7.  Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.

Authors:  P J Hitchcock; T M Brown
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

8.  Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies.

Authors:  J A Mills; J M Buysse; E V Oaks
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

9.  Role of M cells in initial antigen uptake and in ulcer formation in the rabbit intestinal loop model of shigellosis.

Authors:  J S Wassef; D F Keren; J L Mailloux
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

10.  Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp.

Authors:  E V Oaks; T L Hale; S B Formal
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

View more
  30 in total

1.  Mucosal adjuvant properties of the Shigella invasin complex.

Authors:  Robert W Kaminski; K Ross Turbyfill; Edwin V Oaks
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine.

Authors:  R W Kaminski; M Wu; K R Turbyfill; K Clarkson; B Tai; A L Bourgeois; L L Van De Verg; R I Walker; E V Oaks
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

Review 3.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Linkage between Anaplasma marginale outer membrane proteins enhances immunogenicity but is not required for protection from challenge.

Authors:  Susan M Noh; Joshua E Turse; Wendy C Brown; Junzo Norimine; Guy H Palmer
Journal:  Clin Vaccine Immunol       Date:  2013-02-27

5.  Vaccines against gastroenteritis, current progress and challenges.

Authors:  Hyesuk Seo; Qiangde Duan; Weiping Zhang
Journal:  Gut Microbes       Date:  2020-06-18

6.  Immunoproteome analysis of soluble and membrane proteins of Shigella flexneri 2457T.

Authors:  Amy V Jennison; Rubhana Raqib; Naresh K Verma
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

7.  Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants.

Authors:  Ryan T Ranallo; Robert W Kaminski; Tonia George; Alexis A Kordis; Qing Chen; Kathleen Szabo; Malabi M Venkatesan
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

8.  Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis.

Authors:  Maya I Ivanov; Betty L Noel; Ryan Rampersaud; Patricio Mena; Jorge L Benach; James B Bliska
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

9.  Mucosal adjuvanticity of a Shigella invasin complex with dna-based vaccines.

Authors:  Robert W Kaminski; K Ross Turbyfill; C Chao; W M Ching; Edwin V Oaks
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

10.  Detergent Isolation Stabilizes and Activates the Shigella Type III Secretion System Translocator Protein IpaC.

Authors:  Abram R Bernard; Shari M Duarte; Prashant Kumar; Nicholas E Dickenson
Journal:  J Pharm Sci       Date:  2016-06-11       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.